経口寛容および／またはＴｈ２増強サイトカインを用いた自己免疫疾患の治療

Title:

経口寛容および／またはＴｈ２増強サイトカインを用いた自己免疫疾患の治療

Document Type and Number:

Japanese Patent JPH09511990

Kind Code:

A

Abstract:

The invention is directed to methods for treating autoimmune diseases such as multiple sclerosis by orally administering a bystander antigen such as myelin basic protein or proteolipid protein in conjunction with a non-interferon polypeptide having Th2-enhancing cytokine activity in such a manner as to induce oral tolerance to the bystander antigen resulting in suppression of the autoimmune response.

More Like This:

WO/1997/004093	NUCLEOTIDE AND PEPTIDE SEQUENCES FOR TREATING MYASTHENIA
JPH0699479	[Title of Invention] A method for producing a tumor cell growth inhibitor and a tumor-killing cell factor
WO/2002/092055	OXIDIZED COLLAGEN FORMULATIONS FOR USE WITH NON-COMPATIBLE PHARMACEUTICAL AGENTS

Inventors:

ウェイナー，ホワードエル
チェン，ヨウハイ

Application Number:

JP52652295A

Publication Date:

December 02, 1997

Filing Date:

April 07, 1995

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ブリガムアンドウィミンズホスピタル

International Classes:

A61K38/17; A61K38/20; A61K38/26; A61K38/28; A61K38/39; A61K38/43; A61K38/00; A61K39/00; A61P3/08; A61P3/10; A61P13/02; A61P15/00; A61P27/02; A61P29/00; A61P37/00; C07K14/47; (IPC1-7): A61K39/00; A61K38/00; A61K38/17; A61K38/26; A61K38/28; A61K38/43

Attorney, Agent or Firm:

志賀正武（外２名）

Previous Patent: タイプ１インターフェロンを用いた自己免疫疾患の治療法

Next Patent: ロバプラチナ三水和物